Skip to main content

Market Overview

USANA's Hepasil DTX Liver Health Supplement is Now Patent Pending

Share:

USANA Health Sciences, Inc. (NYSE: USNA) today announced that it has filed two new U.S. patents on its popular liver health supplement, Hepasil DTX™.

A science-based company, USANA currently holds patents for Olivol® olive extract, a unique extract that contains antioxidant polyphenols derived exclusively from olives, and its proprietary liquid crystal technology, which is used in USANA's line of self-preserving Sense skincare products.

 

Related Articles (USNA)

View Comments and Join the Discussion!

Posted-In: News FDA

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com